University of Hertfordshire

From the same journal

By the same authors

Do people with intellectual disabilities understand their prescription medication? A scoping review

Research output: Contribution to journalArticlepeer-review

Standard

Do people with intellectual disabilities understand their prescription medication? A scoping review. / Smith, Megan; Adams, Danielle ; Carr, Claudia; Mengoni, Silvana.

In: Journal of Applied Research in Intellectual Disabilities, Vol. 32, No. 6, 01.11.2019, p. 1375-1388.

Research output: Contribution to journalArticlepeer-review

Harvard

APA

Vancouver

Author

Bibtex

@article{b5a6234dbb404eef9f0be506497dc536,
title = "Do people with intellectual disabilities understand their prescription medication? A scoping review",
abstract = "Background: People with intellectual disabilities are more likely to experience poor health than the general population and are frequently prescribed multiple medications. Therefore, it is important that people with intellectual disabilities understand their medication and potential adverse effects. Method: A scoping review explored people with intellectual disabilities' knowledge of prescription medications, their risks and how medication understanding can be improved. Results: Ten journal articles were included. People with intellectual disabilities often lacked understanding of their medication, including its name, purpose and when and how to take it. Participants were often confused or unaware of adverse effects associated with their medication. Information was sometimes explained to carers rather than people with intellectual disabilities. Some interventions and accessible information helped to improve knowledge in people with intellectual disabilities. Conclusion: There is a need for accessible and tailored information about medication to be discussed with people with intellectual disabilities in order to meet legal and best practice standards.",
keywords = "decision making, intellectual disability, medicine, prescriptions",
author = "Megan Smith and Danielle Adams and Claudia Carr and Silvana Mengoni",
note = "{\textcopyright} 2019 The Authors. Journal of Applied Research in Intellectual Disabilities Published by John Wiley & Sons Ltd.",
year = "2019",
month = nov,
day = "1",
doi = "10.1111/jar.12643",
language = "English",
volume = "32",
pages = "1375--1388",
journal = "Journal of Applied Research in Intellectual Disabilities",
issn = "1360-2322",
publisher = "Wiley-Blackwell",
number = "6",

}

RIS

TY - JOUR

T1 - Do people with intellectual disabilities understand their prescription medication? A scoping review

AU - Smith, Megan

AU - Adams, Danielle

AU - Carr, Claudia

AU - Mengoni, Silvana

N1 - © 2019 The Authors. Journal of Applied Research in Intellectual Disabilities Published by John Wiley & Sons Ltd.

PY - 2019/11/1

Y1 - 2019/11/1

N2 - Background: People with intellectual disabilities are more likely to experience poor health than the general population and are frequently prescribed multiple medications. Therefore, it is important that people with intellectual disabilities understand their medication and potential adverse effects. Method: A scoping review explored people with intellectual disabilities' knowledge of prescription medications, their risks and how medication understanding can be improved. Results: Ten journal articles were included. People with intellectual disabilities often lacked understanding of their medication, including its name, purpose and when and how to take it. Participants were often confused or unaware of adverse effects associated with their medication. Information was sometimes explained to carers rather than people with intellectual disabilities. Some interventions and accessible information helped to improve knowledge in people with intellectual disabilities. Conclusion: There is a need for accessible and tailored information about medication to be discussed with people with intellectual disabilities in order to meet legal and best practice standards.

AB - Background: People with intellectual disabilities are more likely to experience poor health than the general population and are frequently prescribed multiple medications. Therefore, it is important that people with intellectual disabilities understand their medication and potential adverse effects. Method: A scoping review explored people with intellectual disabilities' knowledge of prescription medications, their risks and how medication understanding can be improved. Results: Ten journal articles were included. People with intellectual disabilities often lacked understanding of their medication, including its name, purpose and when and how to take it. Participants were often confused or unaware of adverse effects associated with their medication. Information was sometimes explained to carers rather than people with intellectual disabilities. Some interventions and accessible information helped to improve knowledge in people with intellectual disabilities. Conclusion: There is a need for accessible and tailored information about medication to be discussed with people with intellectual disabilities in order to meet legal and best practice standards.

KW - decision making

KW - intellectual disability

KW - medicine

KW - prescriptions

UR - http://www.scopus.com/inward/record.url?scp=85069857394&partnerID=8YFLogxK

U2 - 10.1111/jar.12643

DO - 10.1111/jar.12643

M3 - Article

C2 - 31338972

VL - 32

SP - 1375

EP - 1388

JO - Journal of Applied Research in Intellectual Disabilities

JF - Journal of Applied Research in Intellectual Disabilities

SN - 1360-2322

IS - 6

ER -